In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market.   It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate R&D programs in several domains.   The financial...